Results 161 to 170 of about 1,949,102 (353)

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

Molecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian, Sriraam Sivachandran, Melissa Galati, Brandon Ramchatesingh, Hibo Rijal, Johnny Hanna, Elena Netchiporouk, May Chergui, Margaret Redpath, Samy Abou Setah, Ivan V. Litvinov   +10 more
wiley   +1 more source

Analysis of essential drugs lists of a regional healthcare coordination center in Rio Grande do Sul

O Mundo da Saúde, 2018
In Brazil municipalities are responsible for initiating the guarantee of access to essential medicines by selecting those that will be included in their lists. This study aimed to analyze how the Municipal Lists of Essential Medicines (MLEM) are prepared,
Mariele Salvi, Tatiana Mezadri, Leo Lynce Valle De Lacerda, Luciane Peter Grillo   +3 more
doaj  

SENSITIVITY EVALUATION OF CLINICAL STRAINS OF C. ALBICANS ISOLATED FROM PATIENTS WITH PHARYNGOMYCOSIS TO THE COMBINED EFFECT OF MONARDA ESSENTIAL OIL AND ANTIFUNGAL DRUGS

, 2021
Svitlana V. Zachepylo
openalex   +1 more source

Integrated genomic and proteomic profiling reveals insights into chemoradiation resistance in cervical cancer

Molecular Oncology, EarlyView.
A comprehensive genomic and proteomic analysis of cervical cancer revealed STK11 and STX3 as a potential biomarkers of chemoradiation resistance. Our study demonstrated EGFR as a therapeutic target, paving the way for precision strategies to overcome treatment failure and the DNA repair pathway as a critical mechanism of resistance.
Janani Sambath, Irene A. George, Srikanth S. Manda, Prasanth Ariyannur, Ekta R. Dhawale, Raja Sekhar Kommu, Rajan Datar, Darshana Patil, Vinita Trivedi, Manisha Singh, Kumar Prabhash, Sewanti Limaye, Richa Chauhan, Prashant Kumar   +13 more
wiley   +1 more source

The impact of digestion is essential to the understanding of milk as a drug delivery system for poorly water soluble drugs

, 2018
Ben J. Boyd, Malinda Salim, Andrew J. Clulow, Gisela Ramirez, Anna C. Pham, Adrian Hawley   +5 more
openalex   +2 more sources

Selection of Essential Drugs [PDF]

Tropical Doctor, 1986
openaire   +2 more sources

YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma

Molecular Oncology, EarlyView.
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy, Samuel Hartzler, Paula A. Vargas Carranza, Shyaman Jayasundara, Madison E. Yates, Nimod D. Janson, Bozhi Liu, Annaleigh Benton, Majid Kazemian, Jason A. Hanna   +9 more
wiley   +1 more source

The financial impact of the 'zero-markup policy for essential drugs' on patients in county hospitals in western rural China. [PDF]

PLoS One, 2015
Zhou Z, Su Y, Campbell B, Zhou Z, Gao J, Yu Q, Chen J, Pan Y.   +7 more
europepmc   +1 more source

An evaluation of South Africa's national drug policy: standard treatment guidelines/essential drugs list and its impact on rational drug prescribing at public hospital oupatient clinics: a case study of the Northern Province [PDF]

, 2003
Ariel Rosita King
openalex   +1 more source

Emerging role of ARHGAP29 in melanoma cell phenotype switching

Molecular Oncology, EarlyView.
This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster, Melanie Kappelmann‐Fenzl, Anja Katrin Bosserhoff, Nicole Rachinger   +3 more
wiley   +1 more source